Recombinant UPF0303 protein SAV_5210 (SAV_5210)

Shipped with Ice Packs
In Stock

Description

General Information

UniProt provides protein sequence and functional information on UPF0303 protein SAV_5210 (SAV_5210) .

Recombinant Proteins

Recombinant proteins are utilized in functional assays to study protein interactions, receptor-ligand binding, and enzyme activities .

Research on Plasma-Derived Products

Research is being conducted to improve the safety of plasma-derived products, such as proteins that treat clotting disorders and immune system disorders . Tests are being developed to detect contamination of these products by substances released by microorganisms, even after microbes are filtered out . These tests use cells with toll-like receptors (TLRs) that detect and bind to specific microbial proteins . The FDA intends to make these tests available to the industry to enhance the safety of plasma-derived products .

Affinity Reagents

The NIH Common Fund supported awards aimed at developing and improving methods for obtaining renewable protein affinity reagents . One initiative addressed the challenges in generating protein affinity reagents by supporting the development of a high-throughput antibody selection pipeline . This pipeline could potentially increase throughput by approximately 100-fold compared to traditional methods, significantly reducing costs . Another project focused on developing novel bivalent affinity reagents called NuPromers, which combine a rigid DNA scaffold with two peptides that have affinity against a specific protein target, offering a relatively inexpensive and high-throughput pipeline . A research collaboration aimed to improve screening and evaluation technologies used to generate affinity reagents, comparing different recombinant protein scaffolds and display technologies . Additionally, a Quantitative Parallel Aptamer Selection System (QPASS) platform is being developed to improve aptamer generation, reducing the number of selection rounds and costs .

Analysis of Variability

A method has been proposed for analyzing the variability of smooth functionals of growth or production trajectories associated with processes involving recombinant proteins .

Meta-Analysis of Clinical Outcomes

Two independent meta-analyses of trials involving recombinant human bone morphogenetic protein-2 (rhBMP-2) in spinal fusion showed broad general agreement but differed in several areas . One center found a statistically significant but small benefit, while the other reported no advantage . Analysis of harms showed no increased cancer risk at 48 months in either, although one reported a significant increase at 24 months . These differences highlight the value of data availability to allow multiple approaches and interpretations .

OutcomeCenterSurgical approachNo. of studies (n)Effect size (95% CI)Treatment advantage
ODIAAll12 (1368)(0-100) -3.48 (-6.47 to -0.49)BMP
BALIF5 (423)(0-50) -7.35 (-14.00 to -0.70)BMP
PLF4 (650)(0-50) -1.98 (-4.86 to 0.90)Neither
SF-36 PCSAAll12 (1303)(0-100) 1.93 (0.63 to 3.22)BMP
BALIF5 (421)(0-100) 3.68 (0.86 to 6.49)BMP
PLF4 (644)(0-100) 1.10 (-0.6 to 2.86)Neither
CancerAAll up to 48 months11 (1281)RR 1.98 (0.86 to 4.54)Neither
BAll 24 months5 (1450)RR 3.45 (1.98 to 6.00)Control
All 48 months4 (1183)RR 1.82 (0.84 to 3.95)Neither

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt; aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
Tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its implementation.
Synonyms
SAV_5210; UPF0303 protein SAV_5210
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-163
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)
Target Names
SAV_5210
Target Protein Sequence
MTEAAKPPTI PELEAQERRL TLPHFTYDDA WAFGNLLVEL ARRRCAPVAV DIRRGGQQLF HAALPGSTPD NDAWIDRKRR VVERYGSSSY LVGCRFRAKG TTFEESSRLD PDKYAAHGGA FPITVEGAGV VGTVVVSGLP QVEDHALVVE ALEQFMTRPW SSS
Uniprot No.

Q&A

What is UPF0303 protein SAV_5210 and what experimental systems are used to study it?

UPF0303 protein SAV_5210 belongs to the uncharacterized protein family UPF0303, which represents proteins with currently unknown functions. For experimental expression, researchers can utilize multiple host systems, with E. coli and yeast demonstrating superior yields and shorter production timelines . These expression systems serve as entry points for characterization studies, with the choice of system dependent on experimental objectives and downstream applications.

When designing initial experiments, researchers should consider the following workflow:

  • Expression system selection based on research goals

  • Optimization of expression conditions

  • Development of appropriate purification strategies

  • Validation of protein structure and function

What are the comparative advantages of different expression hosts for UPF0303 protein SAV_5210?

Multiple expression systems demonstrate different advantages when producing recombinant UPF0303 protein SAV_5210. While E. coli and yeast systems provide optimal yields and faster turnaround times, insect and mammalian cell expression systems deliver important post-translational modifications that may be crucial for proper protein folding and biological activity . The following table summarizes the comparative advantages:

Expression SystemYieldTurnaround TimePost-translational ModificationsFolding Efficiency
E. coliHighShortMinimalVariable
YeastHighShortModerateGood
Insect cellsModerateLongerExtensiveVery good
Mammalian cellsLowerLongestMost comprehensiveExcellent

When selecting an expression system, researchers must prioritize the experimental requirements, considering whether native protein conformation or higher yield is more important for their specific research objectives.

How can experimental design be optimized when studying the functional characteristics of UPF0303 protein SAV_5210?

Experimental design for UPF0303 protein SAV_5210 functional characterization should follow rigorous scientific methodology. Researchers should implement a controlled experimental design approach that accounts for variables affecting protein expression and activity . The gold standard approach incorporates:

  • Establishing multiple experimental conditions with appropriate controls

  • Testing the causal relationship between expression conditions and protein yield/activity

  • Ensuring that confounding variables are identified and controlled

  • Implementing both positive and negative controls to validate findings

This approach aligns with the fundamental experimental design principle that strong internal validity requires demonstrating both "if X, then Y" and "if not X, then not Y" relationships . When applying this to UPF0303 protein SAV_5210 research, investigators must systematically vary expression conditions while controlling other variables to establish causal relationships.

What purification strategies yield optimal results for UPF0303 protein SAV_5210?

Purification of UPF0303 protein SAV_5210 requires a multi-step approach to achieve high purity while maintaining protein activity. Based on established protein purification principles, researchers should consider:

  • Initial capture phase using affinity chromatography (if tagged constructs are used)

  • Intermediate purification using ion exchange chromatography

  • Polishing steps with size exclusion chromatography

  • Quality control testing at each purification stage

Each purification step should be validated using SDS-PAGE, Western blotting, and activity assays to ensure that protein integrity and function are maintained throughout the process.

How do post-translational modifications affect the structure and function of UPF0303 protein SAV_5210?

Post-translational modifications (PTMs) significantly impact UPF0303 protein SAV_5210 structure and function. Expression in insect cells with baculovirus or mammalian cells provides many of the post-translational modifications necessary for correct protein folding and activity retention . These modifications may include:

  • Glycosylation patterns that affect protein stability

  • Phosphorylation events that regulate activity

  • Disulfide bond formation critical for tertiary structure

  • Other modifications affecting protein-protein interactions

Researchers investigating PTMs should employ a combination of analytical techniques:

Analytical TechniqueApplicationAdvantage
Mass SpectrometryPTM identification and mappingHigh resolution and sensitivity
Circular DichroismSecondary structure analysisMonitors folding state
Size Exclusion ChromatographyQuaternary structure assessmentDetects aggregation states
Activity AssaysFunctional impact assessmentDirect measure of biological activity

What are common expression challenges with UPF0303 protein SAV_5210 and how can they be addressed?

Researchers frequently encounter expression challenges when producing UPF0303 protein SAV_5210. These challenges and their solutions include:

Protein Misfolding: When expressed in E. coli, UPF0303 protein may misfold due to rapid expression rates and the absence of appropriate chaperones. This can be addressed by:

  • Lowering induction temperature (16-25°C)

  • Co-expressing with molecular chaperones

  • Using specialized E. coli strains designed for difficult proteins

  • Switching to eukaryotic expression systems when necessary

Aggregation: Protein aggregation during expression or purification can be mitigated through:

  • Addition of solubility enhancers to expression media

  • Careful optimization of buffer conditions

  • Inclusion of stabilizing agents during purification

  • Employing on-column refolding techniques if necessary

Low Yield: When expression yields are suboptimal, researchers should:

  • Optimize codon usage for the expression host

  • Test multiple promoter systems

  • Evaluate different fusion tags for improved expression

  • Consider scaling up culture volumes with optimized conditions

How can researchers validate the structural integrity and activity of purified UPF0303 protein SAV_5210?

Validation of UPF0303 protein SAV_5210 structural integrity and activity requires a multi-method approach:

  • Structural Validation:

    • Circular dichroism spectroscopy to assess secondary structure

    • Differential scanning fluorimetry to determine thermal stability

    • Size exclusion chromatography to confirm monomeric state

    • Limited proteolysis to assess domain folding

  • Functional Validation:

    • Development of specific activity assays based on predicted function

    • Binding assays if interaction partners are known

    • Comparative analysis with related proteins of known function

  • Purity Assessment:

    • SDS-PAGE with densitometry analysis (≥95% purity standard)

    • Western blotting with specific antibodies

    • Mass spectrometry for contaminant identification

What mass spectrometry approaches are most effective for characterizing UPF0303 protein SAV_5210?

Mass spectrometry (MS) provides critical insights into UPF0303 protein SAV_5210 structure and modifications. The following MS approaches are particularly valuable:

  • Bottom-up Proteomics: Enzymatic digestion followed by LC-MS/MS analysis provides peptide-level information, useful for:

    • Sequence confirmation

    • Identification of post-translational modifications

    • Mapping of disulfide bonds

  • Top-down MS: Analysis of intact protein provides:

    • Confirmation of full protein mass

    • Heterogeneity assessment

    • Detection of truncated forms

  • Native MS: Analysis under non-denaturing conditions reveals:

    • Quaternary structure information

    • Protein-ligand interactions

    • Conformational states

For comprehensive characterization, researchers should employ multiple complementary MS approaches rather than relying on a single method.

How can researchers design experiments to resolve contradictory data when studying UPF0303 protein SAV_5210?

When confronted with contradictory data regarding UPF0303 protein SAV_5210, researchers should implement a systematic experimental design approach that follows established scientific methodology . This includes:

  • Hypothesis Refinement: Formulate clear, testable hypotheses that address the specific contradictions.

  • Variable Isolation: Design experiments that isolate and test one variable at a time to identify sources of variation.

  • Methodological Triangulation: Apply multiple, complementary techniques to investigate the same property:

    • If studying protein-protein interactions, combine pull-down assays, surface plasmon resonance, and isothermal titration calorimetry

    • For structural studies, integrate X-ray crystallography, NMR, and cryo-EM approaches when possible

  • Validation Across Systems: Test findings in multiple expression systems to distinguish system-specific artifacts from intrinsic protein properties .

  • Statistical Rigor: Apply appropriate statistical methods to determine if differences are significant or within expected variation.

What emerging technologies may enhance our understanding of UPF0303 protein SAV_5210?

Several cutting-edge technologies offer promising avenues for advancing UPF0303 protein SAV_5210 research:

  • Cryo-Electron Microscopy: Provides high-resolution structural information without crystallization, particularly valuable for membrane-associated proteins or complexes.

  • AlphaFold and Other AI Prediction Tools: Computational structure prediction can guide experimental design and provide structural hypotheses when experimental structures are challenging to obtain.

  • Single-Molecule Techniques: Methods like FRET and optical tweezers can reveal dynamic behaviors not observable in ensemble measurements.

  • Integrative Structural Biology: Combining multiple structural techniques (X-ray, NMR, SAXS, crosslinking-MS) provides complementary information that overcomes limitations of individual methods.

  • Proximity Labeling: BioID and APEX techniques can identify interaction partners in cellular contexts, providing functional insights.

Implementation of these technologies requires careful experimental design and consideration of their respective limitations and advantages when applied to UPF0303 protein research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.